Step 1 topics → General Pharmacology → Methemoglobinemia

Methemoglobinemia

USMLE Step 1 trap: Confuses ferric (Fe3+) state of methemoglobin with the normal ferrous (Fe2+) state. Methemoglobin contains Fe3+ (ferric) iron, which cannot bind oxygen.

Methemoglobinemia is a condition where hemoglobin iron is oxidized from Fe2+ (ferrous) to Fe3+ (ferric), rendering it unable to carry oxygen — and USMLE Step 1 tests it primarily through clinical vignettes involving cyanosis that doesn't respond to supplemental oxygen. The result is functional anemia with a left-shifted oxyhemoglobin dissociation curve, meaning even the remaining normal hemoglobin holds onto O2 more tightly. Step 1 expects you to recognize the pattern from drug exposure history (dapsone, benzocaine, nitrites, primaquine), integrate the pulse oximetry artifact, and know when methylene blue fails. The signature lab clue is 'chocolate-colored blood' that doesn't turn red on exposure to air.

The exam hits two main angles: mechanism (what changes about hemoglobin and why) and management (what antidote to use and when it fails). The tricky part is that this isn't just rote recall — Step 1 will embed it in a passage where you need to integrate the drug exposure, the cyanosis, the pulse ox reading, and the arterial blood gas to recognize the pattern. Students who memorize 'give methylene blue' without understanding the G6PD dependency get burned by the follow-up question.

The biggest cognitive traps here are the ferric/ferrous confusion and the pulse oximetry artifact. Many students know methemoglobin is abnormal but incorrectly picture it as still Fe2+. And almost everyone trusts pulse ox readings by default — but in methemoglobinemia, the pulse ox locks in at ~85% regardless of true saturation. Recognizing that a patient looks far worse than the pulse ox suggests, or far better, is the clinical anchor the USMLE Step 1 question writers love to exploit.

From real student decks
16%have cards covering this topic
0%have mature cards

A gap in most decks — fewer than half of students in our cohort have cards covering this topic.

Common misconceptions

Common mistake
Wrong: Methemoglobin contains Fe2+ (ferrous) iron, just like normal hemoglobin.
Right: Methemoglobin contains Fe3+ (ferric) iron, which cannot bind oxygen.
Normal hemoglobin carries oxygen because its iron sits in the Fe2+ (ferrous) state, which can reversibly bind O2. Methemoglobin has iron in the Fe3+ (ferric) state — this positive charge change locks the heme so oxygen cannot bind at all. The distinction matters because the entire pathophysiology and treatment rationale flows from this oxidation state shift.
Common mistake
Wrong: Methylene blue directly reduces Fe3+ back to Fe2+ on its own.
Right: Methylene blue works by activating NADPH-dependent methemoglobin reductase, which requires G6PD-generated NADPH to reduce methemoglobin.
Methylene blue is not a simple reducing agent that chemically grabs electrons from Fe3+. It works by donating electrons to activate NADPH-dependent methemoglobin reductase, which is the enzyme that actually reduces Fe3+ back to Fe2+. That enzyme needs NADPH as a cofactor, and NADPH is generated by the G6PD enzyme in the hexose monophosphate shunt — which is why the whole pathway collapses in G6PD deficiency.
Common mistake
Wrong: Methylene blue is safe and effective in all patients with methemoglobinemia.
Right: Methylene blue is ineffective (and potentially harmful) in G6PD-deficient patients because NADPH cannot be generated; ascorbic acid or exchange transfusion is used instead.
In G6PD-deficient patients, the hexose monophosphate shunt cannot generate NADPH, so giving methylene blue accomplishes nothing — there is no NADPH to drive the reductase. Worse, accumulated methylene blue can itself cause oxidative stress and worsen hemolysis. For these patients, ascorbic acid (a direct non-enzymatic reducing agent) or exchange transfusion is the correct alternative.
Common mistake
Wrong: Pulse oximetry accurately reflects oxygen saturation in methemoglobinemia.
Right: Pulse oximetry falsely reads ~85% in methemoglobinemia regardless of true saturation, because methemoglobin absorbs light at both 660 nm and 940 nm equally.
Standard pulse oximetry distinguishes oxyhemoglobin from deoxyhemoglobin by comparing light absorption at 660 nm versus 940 nm. Methemoglobin absorbs nearly equally at both wavelengths, so the device's algorithm gets confused and defaults to reporting approximately 85% O2 saturation — it doesn't matter if the true saturation is 60% or 99%. Any time you see a patient with severe cyanosis and a pulse ox reading stuck around 85%, or a patient who looks fine but the number seems low, suspect methemoglobinemia and confirm with co-oximetry on an arterial blood gas.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the mechanism: which oxidation state of iron (Fe3+, not Fe2+) defines methemoglobin, which drugs cause it (dapsone, benzocaine, nitrites, primaquine), and why affected hemoglobin cannot carry oxygen.
  2. Know the management: identify methemoglobinemia from clinical clues (cyanosis unresponsive to O2, chocolate-colored blood, ~85% pulse ox), and choose the correct antidote — methylene blue first-line, ascorbic acid or exchange transfusion when G6PD deficiency is present.

Can you avoid these mistakes?

A patient on dapsone for PCP prophylaxis presents with cyanosis and a pulse ox of 85% that doesn't improve with 100% O2. Arterial blood gas shows normal PaO2. What is the diagnosis, what does the chocolate-colored blood tell you, and what is your first-line treatment?
You give methylene blue to a patient with methemoglobinemia and there is no improvement. What underlying condition should you immediately consider, and what is your next management step?
Why does methemoglobin shift the oxyhemoglobin dissociation curve to the left, and what is the clinical consequence of this shift on oxygen delivery to tissues?
A vignette describes a patient with methemoglobinemia and a pulse oximetry reading of 84%. The attending says the true saturation is actually 40%. Explain mechanistically why the pulse ox failed to reflect the true value.

Related topics

ADME and Bioavailability Volume of Distribution (Vd) Clearance and Half-Life First-Order vs Zero-Order Elimination

See how your Anki deck covers this topic.

Upload your deck for a free audit →